Literature DB >> 2969001

Plasma levels of atrial natriuretic hormone in Cushing's syndrome.

T Yamaji1, M Ishibashi, A Yamada, F Takaku, A Itabashi, S Katayama, J Ishii, M Takami, T Fukushima.   

Abstract

To examine a possible role for atrial natriuretic hormone (ANH) in the water and electrolyte disturbances associated with hypercortisolism, plasma ANH levels were measured in 18 patients with endogenous Cushing's syndrome. Nine patients had elevated plasma ANH levels compared to normal subjects. The mean plasma ANH concentration [72.5 +/- 13.0 (+/- SE) pg/mL (23.5 +/- 4.2 pmol/L)] in the Cushing's syndrome patients was significantly higher than that in 40 normal subjects [37.6 +/- 1.9 pg/mL (12.2 +/- 0.62 pmol/L)]. A significant positive correlation was found between plasma ANH and cortisol levels in individual patients. There were no significant correlations, on the other hand, between plasma ANH concentrations and PRA, plasma aldosterone levels, or mean blood pressure. After treatment, plasma ANH concentrations decreased in all 6 patients who had elevated plasma ANH levels preoperatively. In 1 patient with Cushing's disease, plasma ANH levels changed in parallel with plasma cortisol concentrations during o,p'DDD treatment. Fifteen patients who were receiving long term synthetic glucocorticoid therapy for the treatment of miscellaneous diseases had a significantly higher mean plasma ANH level [50.2 +/- 4.0 (+/- SE) pg/mL (16.3 +/- 1.3 pmol/L)] than that in normal subjects. These results suggest that plasma ANH levels are elevated in a substantial number of patients with Cushing's syndrome due to either a direct stimulatory effect of glucocorticoid on atrial ANH secretion or, alternatively, intravascular volume expansion resulting from excessive cortisol secretion.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2969001     DOI: 10.1210/jcem-67-2-348

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  4 in total

1.  Atrial natriuretic peptide in Cushing's disease.

Authors:  G Opocher; S Rocco; G Carpenè; F Pedini; M Scarante; R Milani; M Boscaro; F Mantero
Journal:  J Endocrinol Invest       Date:  1990-02       Impact factor: 4.256

2.  Potent diuretic effects of prednisone in heart failure patients with refractory diuretic resistance.

Authors:  Chao Liu; Gang Liu; Caixia Zhou; Zhenguo Ji; Yuzhi Zhen; Kunshen Liu
Journal:  Can J Cardiol       Date:  2007-09       Impact factor: 5.223

Review 3.  Cardiovascular consequences of cortisol excess.

Authors:  Judith A Whitworth; Paula M Williamson; George Mangos; John J Kelly
Journal:  Vasc Health Risk Manag       Date:  2005

Review 4.  The hypertension of Cushing's syndrome: controversies in the pathophysiology and focus on cardiovascular complications.

Authors:  Andrea M Isidori; Chiara Graziadio; Rosa Maria Paragliola; Alessia Cozzolino; Alberto G Ambrogio; Annamaria Colao; Salvatore M Corsello; Rosario Pivonello
Journal:  J Hypertens       Date:  2015-01       Impact factor: 4.844

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.